SCHEMBL23748384

SCHEMBL23748384

Fc1ccc(-c2ccc(-c3nc4ccc(Cl)cc4o3)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 1/20 0.56
SMN1; SMN2 Q16637 5/20 0.54
KDM4E B2RXH2 3/20 0.54
ALDH1A1 P00352 2/20 0.54
HPGD P15428 2/20 0.54
LMNA P02545 2/20 0.54
NFKB1 P19838 1/20 0.54
NFKB2 Q00653 1/20 0.54
RELA Q04206 1/20 0.54
CASP3 P42574 1/20 0.53
SENP7 Q9BQF6 1/20 0.53
SENP6 Q9GZR1 1/20 0.53
NPC1 O15118 4/20 0.51
RAB9A P51151 4/20 0.51
TP53 P04637 3/20 0.51
TSHR P16473 1/20 0.51
HSD17B10 Q99714 1/20 0.51
MAPT P10636 4/20 0.51
ESR1 P03372 3/20 0.51
ESR2 Q92731 3/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30789017 1.00 HDAC6 (0.56) HDAC6SMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL30965482 0.90 MAPT (0.54) HDAC6SMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL25045583 0.90 MAPT (0.54) HDAC6SMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL10590678 0.89 SMN1; SMN2 (0.61) SMN1; SMN2KDM4EALDH1A1HPGDLMNA
SCHEMBL23748387 0.86 SMN1; SMN2 (0.71) SMN1; SMN2KDM4EALDH1A1HPGDLMNA
SCHEMBL9115618 0.86 SMN1; SMN2 (0.72) SMN1; SMN2KDM4EALDH1A1HPGDLMNA
SCHEMBL28173331 0.85 HDAC6 (0.62) HDAC6SMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL24106599 0.84 NPC1 (0.73) SMN1; SMN2KDM4EALDH1A1HPGDLMNA
SCHEMBL30965463 0.84 NPC1 (0.73) SMN1; SMN2KDM4EALDH1A1HPGDLMNA
SCHEMBL30788998 0.84 CETP (0.51) HDAC6SMN1; SMN2KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3863755-A1 BENZOXAZOLE AND RELATED COMPOUNDS USEFUL AS CHAPERONE-MEDIATED AUTOPHAGY MODULATORS Albert Einstein College of Medicine (US) 2021-08-18 EP claimed
US-20210387953-A1 BENZOXAZOLE AND RELATED COMPOUNDS USEFUL AS CHAPERONE-MEDIATED AUTOPHAGY MODULATORS ALBERT EINSTEIN COLLEGE OF MEDICINE 2021-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210387953-A1 BENZOXAZOLE AND RELATED COMPOUNDS USEFUL AS CHAPERONE-MEDIATED AUTOPHAGY MODULATORS CLPX, SQSTM1, ATG7 HDAC6 67/4885SMN1; SMN2 2666/4885KDM4E 3005/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.